Grace Therapeutics, Inc. (GRCE)

Net Income

-$21.45M

TTM · Period ending: · USD

GRCE logo

GRCE Net Income

Latest reported-$21.45M
GRCE TTM Net Income (-$1.27M → -$21.45M)
High-resolution chart · PNG

GRCE net income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Grace Therapeutics, Inc. Net Income — Trailing twelve months (TTM) (USD)
Period endingNet Income (USD)
-21,452,736
-9,024,736
-6,941,003
-9,739,786
-11,863,530
-12,080,617
-17,282,643
-14,476,633
-15,477,027
-17,227,462
-52,272,257
-54,328,431
-54,825,037
-55,320,489
-20,857,344
-20,446,917
-14,274,909
-13,219,008
-17,251,331
-17,686,291
-29,810,838
-33,624,533
-365,837
-7,238,877
-17,515,338
-17,778,570
-55,226,701
-46,488,354
-42,922,323
-39,718,810
-32,643,240
-34,092,781
-20,133,936
-16,627,449
-12,387,410
-9,332,341
-8,117,446
-7,353,945
-7,208,680
-6,366,433
-4,725,282
-5,247,963
-979,860
-3,456,978
-1,429,835
-1,437,506
-7,698,850
-7,356,570
-10,513,248
-10,370,236
-8,360,064
-7,053,078
-6,675,829
-6,656,736
-7,172,203
-7,168,525
-6,686,714
-5,953,890
-4,422,334
-3,327,532
-2,793,957
-2,186,106
-1,958,059
-1,721,583
-1,484,584
-1,273,330
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.